Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1861 AL 1875

Targeting Sirtuin Signaling in Parkinson's Disease and Neurodegeneration: Molecular Insights and Translational Potential

Kumari S, Singh H, Vaidya S, Taliyan R.

Mol Neurobiol. 2026 Jul 17;63(1):775. doi: 10.1007/s12035-026-06062-w.

Targeting neuroinflammation and neurodegeneration in Parkinson's disease: Emerging natural and synthetic therapeutic strategies

Arbab S, Ullah H, Han Y, Zhou J, Ka L.

Ageing Res Rev. 2026 Oct;121:103263. doi: 10.1016/j.arr.2026.103263. Epub 2026 Jul 17.

Brain organoids in Parkinson's disease drug development: Human-specific models for translational discovery

Zagare A, Jarazo J, Schwamborn J.

Drug Discov Today. 2026 Jul;31(4):104742. doi: 10.1016/j.drudis.2026.104742. Epub 2026 Jul 17.

Microneedle-mediated drug delivery systems for brain diseases

Li J, Wang Y, Ma X, Bi X, Wu T, Zhang N, Wang F, Liu T, Geng F.

Nanomedicine. 2026 Jul 17;76:102996. doi: 10.1016/j.nano.2026.102996. Online ahead of print.

Focused ultrasound blood brain barrier opening for targeted therapeutics in neurodegenerative diseases

Halabian N, Park C, Omoto L, Bocca LF, Palacios G, Wu K, Hamani C, Rabin J, Abrahao A, Davidson B, Lipsman N, Meng Y.

Biol Psychiatry. 2026 Jul 17:S0006-3223(26)01399-5. doi: 10.1016/j.biopsych.2026.07.008. Online ahead of print.

From neural loss to regeneration: modulating cell death to enhance pluripotent stem cell graft survival and integration

Chen O, Hui KK, Raudzus F, Henderson JT.

Cell Death Dis. 2026 Jul 17. doi: 10.1038/s41419-026-09066-5. Online ahead of print.

Coffee as a polypharmacological modulator of mitochondrial health: from molecular mechanisms to translational implications

Jiang Z, Ding Y.

J Transl Med. 2026 Jul 17. doi: 10.1186/s12967-026-08662-5. Online ahead of print.

Sustainable next-generation prebiotics for brain health: microbiota-gut-brain axis in neurodegenerative and demyelinating diseases

Barrera-Chamorro L, Gonzalez-de la Rosa T, Arzalluz-Luque J, Torrecillas-Lopez M, Marquez-Paradas E, Claro-Cala CM, Navarro-Hortal MD, Eichau S, Garcia-Sanchez MI, Montserrat-de la Paz S.

Crit Rev Food Sci Nutr. 2026 Jul 18:1-22. doi: 10.1080/10408398.2026.2703335. Online ahead of print.

Pre-Excited Atrial Fibrillation in a Young Woman with Wolff-Parkinson-White Syndrome Managed with Catheter Ablation Abroad and Followed in a Low-Resource Setting: A Case Report from Somalia

Mohamud MA, Hassan HH, Ahmed SA, Hashi KI, Mohamed AJ, Hussein AA.

Int Med Case Rep J. 2026 Jul 14;19:621793. doi: 10.2147/IMCRJ.S621793. eCollection 2026.

Delayed circumflex artery stenosis following endocardial left posterolateral accessory pathway ablation

Cherbi M, Van der Heyden J, le Polain de Waroux JB, Duytschaever M, Tavernier R, Knecht S.

HeartRhythm Case Rep. 2026 Apr 22;12(7):846-850. doi: 10.1016/j.hrcr.2026.04.020. eCollection 2026 Jul.

Evaluating the pharmacokinetics, efficacy and safety of low-dose cannabidiol

Warren WG, Osborn M, Yates A, O'Sullivan SE.

Br J Clin Pharmacol. 2026 Oct;92(10):3301-3315. doi: 10.1002/bcp.70691. Epub 2026 Jul 19.

Pharmacokinetics and Bioequivalence Study of Levodopa and Benserazide Tablets in Healthy Chinese Subjects Under Fasting and High-Fat Meal Conditions

Liang Y, Wang Y, Shi R, Pei Y, Zhao X, Wang Q, Ren Y, Xie Z, Zhao K.

Clin Pharmacol Drug Dev. 2026 Jul;15(7):e70080. doi: 10.1002/cpdd.70080.

Return of genetic results to persons with Parkinson's disease: Blessing or foe?

Shiner T, Alcalay RN.

J Parkinsons Dis. 2026 Jul 20:1877718X261470605. doi: 10.1177/1877718X261470605. Online ahead of print.

Unlocking new uses: The promise of antidepressants in treating Alzheimer's and Parkinson's through Neuroinflammation modulation

Abbaszadeh F, Amini NB, Davoody S, Rezaei M, Ghasemi R, Javadpour P.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Jul 20;149:111848. doi: 10.1016/j.pnpbp.2026.111848. Online ahead of print.

Comparing token-based and trajectory-based vowel space metrics for assessing speech in Parkinson's disease

Abur D, Cushman M, Dunsmuir CJ, Stepp CE.

PLoS One. 2026 Jul 21;21(7):e0353680. doi: 10.1371/journal.pone.0353680. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias